InsiderTrades

Form 4 for TDOC Teladoc Health, Inc.

Accepted 2025-03-21 00:00:00 ET · period of report 2025-03-19 · accession 0001477449-25-000030 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-03-21 2025-03-20 TDOC Nueno Carlos Pres, International S - Sale+OE $8.42 -8,266 12.9K -39% -$69.6K
D 2025-03-21 2025-03-19 TDOC Nueno Carlos Pres, International M - OptEx — +18.2K 21.2K +622% —
D 2025-03-21 2025-03-19 TDOC Nueno Carlos Pres, International M - OptEx $0.00 -18.2K 36.5K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-03-20 S D 8,266 $8.42 12,891 D — — (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
2 Common Common Stock 2025-03-19 M A 18,225 — 21,157 D — — (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
3 Derivative Restricted Stock Units 2025-03-19 M D 18,225 $0.00 36,450 D — · — to — 18,225 Common Stock (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F3) On March 19, 2024, the reporting person was granted 54,675 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.